Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of the Effect and Safety of Three New Oral Sprays and a Reference Marketed Oral Spray in the Relief of Drug-induced Xerostomia Associated With Hyposialia.

NCT02005328 is registered in ClinicalTrials.gov with Pierre Fabre Medicament as lead sponsor.

NCT NCT02005328
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02005328 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of the Effect and Safety of Three New Oral Sprays and a Reference Marketed Oral Spray in the Relief of Drug-induced Xerostomia Associated With Hyposialia.
Lead sponsor
Pierre Fabre Medicament
Phase
Not applicable
Overall status
Completed
Start date
December 31, 2013
Completion date
February 28, 2014
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

drug-induced xerostomia